Renal Impairment: Dedicated studies in patients with renal impairment have not been performed, as ~1.1% of neratinib is excreted through the kidneys in a radio labeled mass balance study in healthy subjects. PPK analysis indicated that mild renal impairment (based on creatinine clearance) is not a covariate for PK of neratinib. No dose adjustment is needed for renal impairment.